CYP3A4 Cancer Research Results
CYP3A4, CYP3A4: Click to Expand ⟱
| Source: |
| Type: |
CYP3A4 is the most abundant cytochrome P450 enzyme in the liver and is also expressed in extrahepatic tissues.
– It metabolizes a wide range of drugs and endogenous substrates, including hormones.
– In some studies, higher CYP3A4 expression has been correlated with poorer response to treatment and potentially worse survival.
|
Scientific Papers found: Click to Expand⟱
*other?, *P-gp↑, *CYP3A4↑,
*BioAv↓, Half-Life∅, *BioAv↓, Dose∅, eff↑, CYP1A2↓, CYP2C9↓, CYP3A4↓,
CYP3A4↓, Apoptosis↑, AntiTum↑,
Dose↝, BioAv↑, Half-Life↑, CYP3A4↓, PSA↓,
P450↓, CYP3A4↓, CYP2C9↓,
| - |
Review, |
Nor, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
*eff↑, *eff↑, *toxicity↝, *Inflam↓, *Bacteria↓, *neuroP↑, *Half-Life↝, *BBB↑, *BioEnh↑, *P-gp↓, *CYP3A4↓, *ROS↓, *neuroP↑,
*CYP3A4↓,
Risk↓, AntiCan↑, TumCP↓, TumMeta↓, ChemoSen↑, *BioAv↑, *other↝, *Dose↝, Dose↓, *BioAv↑, *Dose↝, *Half-Life↝, *toxicity↝, GSH↓, ROS↑, CYP1A1↑, CYP1A2↑, P450↓, CYP2E1↑, CYP3A4↓, CYP2A3/CYP2A6↓, *ROS↓, *GPx1↑, *SOD1↑, *SOD2↑, Akt↓, EGFR↓, HER2/EBBR2↓, P53↑, Telomerase↓, selectivity↑, MMP↓, Cyt‑c↑, Apoptosis↑, DR4↑, Fas↑, XIAP↓, survivin↓, TumAuto↑, Hif1a↓, angioG↓, MMPs↓, ERK↓, NF-kB↓, EMT↓, TumCI↓, TumCMig↓, Glycolysis↓, ATP↓, selectivity↑, *antiOx↑, Dose↝, other↝, OCR↓, GSH↓, ITGB1↓, ITGB6↓, ChemoSen↑,
TumCCA↑, CYP1A1↓, CYP3A4↓, Cyt‑c↑, Casp9↑, Apoptosis↑, ROS↑, MAPK↑, P53↑, BAX↑, ChemoSen↑, HDAC↓, GSH↓, HO-1↑,
Showing Research Papers: 1 to 9 of 9
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 9
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
CYP1A1↓, 1, CYP1A1↑, 1, CYP2E1↑, 1, GSH↓, 3, HO-1↑, 1, ROS↑, 2,
Mitochondria & Bioenergetics ⓘ
ATP↓, 1, MMP↓, 1, OCR↓, 1, XIAP↓, 1,
Core Metabolism/Glycolysis ⓘ
CYP3A4↓, 6, Glycolysis↓, 1,
Cell Death ⓘ
Akt↓, 1, Apoptosis↑, 3, BAX↑, 1, Casp9↑, 1, Cyt‑c↑, 2, DR4↑, 1, Fas↑, 1, MAPK↑, 1, survivin↓, 1, Telomerase↓, 1,
Kinase & Signal Transduction ⓘ
HER2/EBBR2↓, 1,
Transcription & Epigenetics ⓘ
other↝, 1,
Autophagy & Lysosomes ⓘ
TumAuto↑, 1,
DNA Damage & Repair ⓘ
P53↑, 2,
Cell Cycle & Senescence ⓘ
TumCCA↑, 1,
Proliferation, Differentiation & Cell State ⓘ
EMT↓, 1, ERK↓, 1, HDAC↓, 1,
Migration ⓘ
ITGB1↓, 1, ITGB6↓, 1, MMPs↓, 1, TumCI↓, 1, TumCMig↓, 1, TumCP↓, 1, TumMeta↓, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 1, EGFR↓, 1, Hif1a↓, 1,
Immune & Inflammatory Signaling ⓘ
NF-kB↓, 1, PSA↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↑, 1, ChemoSen↑, 3, CYP1A2↓, 1, CYP1A2↑, 1, CYP2A3/CYP2A6↓, 1, CYP2C9↓, 2, Dose↓, 1, Dose↝, 2, Dose∅, 1, eff↑, 1, Half-Life↑, 1, Half-Life∅, 1, P450↓, 2, selectivity↑, 2,
Clinical Biomarkers ⓘ
EGFR↓, 1, HER2/EBBR2↓, 1, PSA↓, 1,
Functional Outcomes ⓘ
AntiCan↑, 1, AntiTum↑, 1, Risk↓, 1,
Total Targets: 62
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 1, GPx1↑, 1, ROS↓, 2, SOD1↑, 1, SOD2↑, 1,
Core Metabolism/Glycolysis ⓘ
CYP3A4↓, 2, CYP3A4↑, 1,
Transcription & Epigenetics ⓘ
other?, 1, other↝, 1,
Barriers & Transport ⓘ
BBB↑, 1, P-gp↓, 1, P-gp↑, 1,
Immune & Inflammatory Signaling ⓘ
Inflam↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 2, BioAv↑, 2, BioEnh↑, 1, Dose↝, 2, eff↑, 2, Half-Life↝, 2,
Functional Outcomes ⓘ
neuroP↑, 2, toxicity↝, 2,
Infection & Microbiome ⓘ
Bacteria↓, 1,
Total Targets: 22
Scientific Paper Hit Count for: CYP3A4, CYP3A4
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1131 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid
Home Page